Biologics
Porton Advanced and BRL Medicine Partner to Fast-Track Gene and Cell Therapy Commercialization
BRL Medicine, with its strong gene editing technology, robust R&D capabilities, and prospective pipelines, has been devoted to the realm of CGT for yea...
September 15, 2023 | News
Singleron Unveils AccuraCode® TCR Kit for Streamlined T-Cell Profiling
The product is built upon Singleron's molecular barcoding technology, enabling multiplexing of 96 or 384 samples in a single library construction reaction....
September 14, 2023 | News
Metabolon Debuts Stress Discovery Panel for Biomarker Detection
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, diagnostic, therapeutic development, and preci...
September 13, 2023 | News
Waters Introduces Simplified Solutions for Biologic Drug Analysis
Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and...
September 13, 2023 | News
MGI Launches the DCS Lab Initiative to Expand Global Omics Access and Capabilities
"We are proud that through the DCS Lab Initiative, MGI technology and innovation will empower researchers and scientists in achieving their next breakthrou...
September 12, 2023 | News
Lonza Upgrades MODA-ES® Module for Enhanced Electronic Batch Record Execution
The MODA-ES® Module v4.0 is an electronic batch record solution that helps pharmaceutical customers to expedite batch release by minimizing p...
September 11, 2023 | News
Mabwell and WuXi XDC Forge Long-Term ADC Partnership for Biologics Expansion
Mabwell has had multiple innovative products in clinical studies or preclinical research by their world-leading ADC technology platforms and CMC developmen...
September 11, 2023 | News
Verily and Kyverna Collaborate to Advance Cell Therapy for Autoimmune Diseases
Verily, an Alphabet precision health technology company, and Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company engineering a new clas...
September 08, 2023 | News
Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment
The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...
September 07, 2023 | News
Gloria Biosciences' Zimberelimab Approved in China for Recurrent Cervical Cancer
Guangzhou Gloria Biosciences ("GloriaBio"), a commercial stage biopharmaceutical company focusing on the discovery, development and commercialization of bi...
September 07, 2023 | News
Biocon Biologics Expands Global Presence, Completes Viatris Biosimilars Integration in North America Ahead of Schedule.
To further strengthen its leadership position in the global biosimilars industry and provide complete end-to-end capabilities to patients and customers, Bi...
September 07, 2023 | News
Isotopia Issues a call to action to the radionuclide Therapy industry.
The Lu-177 radiopharmaceuticals sector stands at a critical juncture, necessitating urgent collaboration. Our shared duty as supply chain stewards has neve...
September 07, 2023 | News
"Advancing Precision Oncology: Dr. Jerome Boyd-Kirkup Discusses Breakthroughs in HMBD-001 Trials"
In this exclusive interview with Dr. Jerome Boyd-Kirkup, Chief Scientific Officer of Hummingbird Bioscience, BioPharma APAC delve into the recently i...
September 06, 2023 | News
Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows
Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, today launched the Yourgene® MagBenc...
September 06, 2023 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
